Mahoney Stephen F.

Viridian Therapeutics, Inc.\de

President and CEO, Director

Avg. Two Year Performance

No Purchase Track Record

No Sale Track Record

Holdings: 21.4K shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

$499.26K Net Amount

Buy:	$499.26K	$23.33
Sell:	0	--

Sentiment

Insider Trading Sentiment: Strong Buy

Company Sentiment

Medical Laboratories & Research

Health Services

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions